Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cryptocurrency
  • News
  • Top Stories

Bitcoin Drops Below $65K: ‘Summer Time Sadness’ Coming?

By Khyathi Dalal
June 18, 9:29 AM
Crypto trader Stockmoney Lizards expressed concerns about Bitcoin’s (CRYPTO: BTC) short-term performance, hinting at a possib

BTC

Read More
1 minute read
  • Biotech
  • General
  • News

Neurogene Reports First Patient Dosed In High-Dose Cohort Of NGN-401 Gene Therapy Clinical Trial For Rett Syndrome

By Benzinga Newsdesk
June 18, 9:28 AM
High-dose NGN-401 has been well-tolerated, and low-dose NGN-401 continues to show a favorable safety profileInterim safety data presented at the International Rett Syndrome Foundation (IRSF) ASCEND SummitNeurogene Inc.

NGNE

Read More
2 minute read
  • Asia
  • Commodities
  • Top Stories

Brazil Implements Plan To Become A Key Rare Earth Elements Supplier

By Stjepan Kalinic
June 18, 9:26 AM
Brazil, holding the world's third-largest REE reserves, has significantly advanced in this sector with the launch of the Serra Verde mine.

APAAF

Read More
1 minute read
  • News

CrowdStrike Sets 4 Minute Record For Fastest Threat Detection In MITRE Engenuity’s ATT&CK Evaluations: Managed Services-Round 2

By Benzinga Newsdesk
June 18, 9:26 AM
CrowdStrike detects advanced adversary attack in real-world, closed-book simulation in just four minutes, six to 11 times faster than competitive vendors; scores highest in detection coverage at 98%CrowdStrike

CRWD

Read More
2 minute read
  • Movers
  • News

What’s Going On With Palantir Stock Tuesday?

By Adam Eckert
June 18, 9:25 AM
Palantir shares closed Monday up 6.15% after Argus Research analyst Joseph Bonner initiated coverage on the stock with a Buy rating and announced a price target of $29, highlighting momentum around the company's commercial business.

PLTR

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Long Ideas
  • Tech
  • Technicals
  • Top Stories
  • Trading Ideas

Qualcomm Stock Surges With Samsung Partnership For Galaxy S25: What’s Driving The Growth?

By Surbhi Jain
June 18, 9:25 AM
Qualcomm (QCOM) stock surges on news of Samsung's switch to their next-gen chipset, highlighting robust demand and potential for growth.

QCOM

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

By Vandana Singh
June 18, 9:22 AM
AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN

Read More
2 minute read
  • Insider Trades
  • Long Ideas
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

$176M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying

By Avi Kapoor
June 18, 9:20 AM
Although U.S. stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares,…

BYON

Read More
2 minute read
  • Analyst Ratings
  • Earnings
  • Markets
  • News
  • Price Target
  • Trading Ideas

Darden Restaurants Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

By Avi Kapoor
June 18, 9:19 AM
Darden Restaurants, Inc. (NYSE:DRI) will release earnings results for its fiscal 2024 fourth quarter, before the opening bell…

DRI

Read More
1 minute read
  • Equities
  • General
  • Markets
  • Movers
  • News

What’s Going On With Trump Media & Technology Shares Today?

By Nabaparna Bhattacharya
June 18, 9:17 AM
Trump Media & Technology Group shares are down in premarket trading despite a recent surge, as the company addresses short selling concerns and plans expansion into streaming and media acquisitions.

DJT

Posts pagination

Previous 1 … 62 63 64 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service